Skip to main content

Peer Review reports

From: Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

Original Submission
22 Dec 2021 Submitted Original manuscript
9 Jan 2022 Reviewed Reviewer Report - Florentia Fostira
29 Jan 2022 Reviewed Reviewer Report - Olga Haus
11 Feb 2022 Author responded Author comments - Alicja Ogrodniczak
Resubmission - Version 2
11 Feb 2022 Submitted Manuscript version 2
20 Feb 2022 Reviewed Reviewer Report - Florentia Fostira
7 Mar 2022 Author responded Author comments - Alicja Ogrodniczak
Resubmission - Version 3
7 Mar 2022 Submitted Manuscript version 3
Publishing
8 Mar 2022 Editorially accepted
21 Mar 2022 Article published 10.1186/s13053-022-00218-0

You can find further information about peer review here.

Back to article page